查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941419

传染性呼吸道疾病诊断市场规模、份额和趋势分析报告：按产品、应用、技术、最终用途、地区和细分市场预测，2026-2033年

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis By Product, By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

传染性呼吸道疾病诊断市场概述

全球传染性呼吸道疾病诊断市场预计到 2025 年价值 125.6 亿美元，预计到 2033 年将达到 157 亿美元。

预计从 2026 年到 2033 年，该市场将以 2.90% 的复合年增长率成长。推动市场成长的几个关键因素包括结核病和肺炎等疾病的增加、诊断技术的进步以及主要企业之间日益增多的合作与伙伴关係。

例如，2023年2月，赛默飞世尔科技（Thermo Fisher Scientific）和MyLab Discovery Solutions宣布建立合作伙伴关係，共同开发和分销用于感染疾病的诊断检测套组，包括耐多药结核病、乙型肝炎病毒、C型肝炎病毒、爱滋病毒以及基因分析（HLA B27），业务遍及印度。此次合作结合了赛默飞世尔的全球专业知识和MyLab的在地化生产能力，旨在扩大高品质侦测解决方案的覆盖范围。

增加结核病诊断计画的资金投入对于对抗这一全球性疾病至关重要。目前用于预防、诊断和治疗的资金不足以满足需求，阻碍了降低发病率和死亡率的进展。例如，儘管到2027年每年计划投入220亿美元，另有50亿美元用于研究，但仅有58亿美元被分配给结核病防治服务——远低于实现全球目标所需的金额。此外，世界卫生组织强调需要持续增加资金投入才能有效消除结核病。为此，美国政府已大幅增加结核病防治资金，从2013年的2.33亿美元增加到2023年的4.06亿美元。筛检和预防性治疗的投资已证明具有显着的健康和经济效益，每投入1美元，即可产生高达39美元的投资回报。

目录

第一章调查方法和范围

第二章执行摘要

3. 传染性呼吸道疾病诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 传染性呼吸道疾病诊断市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 传染性呼吸道疾病诊断市场：依产品分類的估算与趋势分析

  • 传染性呼吸道疾病诊断市场：依产品分類的差异分析
  • 传染性呼吸道疾病诊断市场：产品展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 装置
  • 试剂
  • 服务

第五章感染疾病和呼吸系统疾病诊断市场：按技术分類的估计和趋势分析

  • 传染性呼吸道疾病诊断市场：依技术分類的差异分析
  • 传染性呼吸道疾病诊断市场：技术展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 免疫检测
  • 分子诊断
  • 微生物学
  • 快速/照护现场
  • 其他的

第六章 传染性呼吸道疾病诊断市场：按应用分類的估算与趋势分析

  • 传染性呼吸道疾病诊断市场：按应用分類的差异分析
  • 传染性呼吸道疾病诊断市场：按应用领域分類的展望
  • 市场规模、预测与趋势分析（2021-2033）
  • COVID-19
  • 流感
  • 呼吸道融合病毒（RSV）
  • 结核
  • 非结核分枝桿菌检测
  • 细菌性肺炎检测
  • 其他的

7. 传染性呼吸道疾病诊断市场：依最终用途分類的估算与趋势分析

  • 传染性呼吸道疾病诊断市场：依最终用途分類的差异分析
  • 传染性呼吸道疾病诊断市场：依最终用途分類的视角
  • 市场规模、预测与趋势分析（2021-2033）
  • 医院
  • 诊断检查室
  • 研究所
  • 诊所

第八章 传染性呼吸道疾病诊断市场：区域估算与趋势分析

  • 区域仪錶板
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 市场参与企业分类
  • 主要市场参与企业的最新趋势和影响分析
  • 企业市场占有率分析（2025）
  • 主要企业简介
    • ABBOTT
    • F. Hoffmann-La Roche Ltd
    • BD
    • KONINKLIJKE PHILIPS NV
    • BIOMERIEUX SA
    • BIO-RAD LABORATORIES, INC.
    • QUIDEL CORPORATION
    • CEPHEID
    • QIAGEN
    • SIEMENS HEALTHCARE GMBH
    • Seegene Inc.
    • EliTechGroup（Bruker Corporation）
    • CERTEST BIOTEC
    • Thermo Fisher Scientific, Inc.
Product Code: GVR-4-68039-976-4

Infectious Respiratory Disease Diagnostics Market Summary

The global infectious respiratory disease diagnostics market size was estimated at USD 12.56 billion in 2025 and is projected to reach USD 15.70 billion by 2033, growing at a CAGR of 2.90% from 2026 to 2033. The market is being driven by several key factors, including the growing prevalence of diseases like tuberculosis and pneumonia, advancements in diagnostic technologies, and increased partnerships and collaborations between major players.

For instance, in February 2023, Thermo Fisher Scientific and Mylab Discovery Solutions announced a partnership to develop and distribute diagnostic test kits for infectious diseases such as multi-drug-resistant tuberculosis, hepatitis B virus, hepatitis C virus, HIV, and genetic analysis (HLA B27) in India. The collaboration aims to combine Thermo Fisher's global expertise with Mylab's local manufacturing capabilities to expand access to high-quality testing solutions.

The increasing funding for TB diagnosis programs is crucial in the fight against this global disease. The current funding for prevention, diagnosis, and treatment is insufficient to meet the demand, hindering progress in reducing incidence & mortality rates. For instance, an annual investment of USD 22 billion by 2027 was set, with an additional USD 5 billion for research, and only USD 5.8 billion was allocated for TB services, falling short of the required amounts to achieve global targets. Moreover, WHO emphasizes the need for sustained & increased funding to combat TB effectively. Hence, the U.S. government has significantly increased its funding for TB initiatives, from USD 233 million in 2013 to USD 406 million in 2023. Investments in screening and preventive treatment have shown significant health & economic benefits, with a return on investment of up to USD 39 for every dollar spent.

Global Infectious Respiratory Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global infectious respiratory disease diagnostics market report based on technology, pathogen, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • COVID-19
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • Tuberculosis
  • Non-tuberculosis Mycobacterium Testing
  • Bacterial Pneumonia Testing
  • Other Respiratory Disease Testing
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoassay
  • Molecular Diagnostics
  • Microbiology
  • Rapid/Point-of-Care Diagnostics
  • Other Technologies
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
    • 1.2.3. End Use
    • 1.2.4. Application
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Infectious Respiratory Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High Prevalence Of Infectious Respiratory Diseases Globally
      • 3.2.1.2. Technological Advancement In Respiratory Disease Testing
      • 3.2.1.3. Rising R&D Investments In Respiratory Disease Testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Prices Of Diagnostic Products
      • 3.2.2.2. Presence Of Ambiguous Regulatory Framework
  • 3.3. Infectious Respiratory Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Infectious Respiratory Disease Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Infectious Respiratory Disease Diagnostics Market: Product Movement Analysis
  • 4.3. Infectious Respiratory Disease Diagnostics Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 4.5. Instruments
    • 4.5.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Reagents
    • 4.6.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Services
    • 4.7.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Infectious Respiratory Disease Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
  • 5.3. Infectious Respiratory Disease Diagnostics Market by Technology Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 5.5. Immunoassay
    • 5.5.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Microbiology
    • 5.7.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Rapid/Point-of-Care Diagnostics
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Other Technologies
    • 5.9.1. Other Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Infectious Respiratory Disease Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
  • 6.3. Infectious Respiratory Disease Diagnostics Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 6.5. COVID-19
    • 6.5.1. COVID-19 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Influenza
    • 6.6.1. Influenza Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Respiratory Syncytial Virus
    • 6.7.1. Respiratory Syncytial Virus Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Tuberculosis
    • 6.8.1. Tuberculosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Non-tuberculosis Mycobacterium Testing
    • 6.9.1. Non-tuberculosis Mycobacterium Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Bacterial Pneumonia Testing
    • 6.10.1. Bacterial Pneumonia Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Other Respiratory Disease Testing
    • 6.11.1. Other Respiratory Disease Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Infectious Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Infectious Respiratory Disease Diagnostics Market: End Use Movement Analysis
  • 7.3. Infectious Respiratory Disease Diagnostics Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Diagnostic Laboratories
    • 7.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Research Institutes
    • 7.7.1. Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Clinics
    • 7.8.1. Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Infectious Respiratory Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Recent Developments & Impact Analysis by Key Market Participants
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Key Company Profiles
    • 9.4.1. ABBOTT
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. F. Hoffmann - La Roche Ltd
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. BD
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. KONINKLIJKE PHILIPS N.V.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. BIOMERIEUX SA
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. BIO-RAD LABORATORIES, INC.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. QUIDEL CORPORATION
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. CEPHEID
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. QIAGEN
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. SIEMENS HEALTHCARE GMBH
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Seegene Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. EliTechGroup (Bruker Corporation)
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. CERTEST BIOTEC
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Thermo Fisher Scientific, Inc.
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 6 Global infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 7 North America infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 8 North America infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 9 North America infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 10 North America infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 12 U.S infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 13 U.S infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 14 U.S infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 15 Canada infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 16 Canada infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 17 Canada infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 18 Canada infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Mexico infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 20 Mexico infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 21 Mexico infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 22 Mexico infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 Europe infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 24 Europe infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 25 Europe infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 26 Europe infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 27 UK infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 28 UK infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 29 UK infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 30 UK infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 31 Germany infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 32 Germany infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 33 Germany infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 34 Germany infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 France infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 36 France infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 37 France infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 38 France infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 39 Italy infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 40 Italy infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 41 Italy infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 42 Italy infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 43 Spain infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 44 Spain infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 45 Spain infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 46 Spain infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Denmark infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 48 Denmark infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 49 Denmark infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 50 Denmark infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Sweden infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Sweden infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 53 Sweden infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 54 Sweden infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 55 Norway infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 56 Norway infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 57 Norway infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 58 Norway infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 Japan infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Japan infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Japan infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 66 Japan infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 67 China infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 68 China infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 69 China infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 70 China infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 India infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 72 India infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 73 India infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 74 India infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 75 Australia infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 76 Australia infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 77 Australia infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 Australia infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 South Korea infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 80 South Korea infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 81 South Korea infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 82 South Korea infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 85 Thailand infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 86 Thailand infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Latin America infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 88 Latin America infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 89 Latin America infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 90 Latin America infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Brazil infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 92 Brazil infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 93 Brazil infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 94 Brazil infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Argentina infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 96 Argentina infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 97 Argentina infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 98 Argentina infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 99 Middle East & Africa infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 100 Middle East & Africa infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 101 Middle East & Africa infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 102 Middle East & Africa infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 103 South Africa infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 104 South Africa infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 105 South Africa infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 106 South Africa infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 111 UAE infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 112 UAE infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 113 UAE infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 114 UAE infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 115 Kuwait infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 116 Kuwait infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 117 Kuwait infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 118 Kuwait infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Infectious respiratory disease diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Infectious respiratory disease diagnostics market, Product outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 12 Infectious respiratory disease diagnostics market, Technology outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 13 Infectious respiratory disease diagnostics market, Application outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 14 Infectious respiratory disease diagnostics market, End Use outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 15 Instruments market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Reagents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Services market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Immunoassay market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Molecular Diagnostics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Microbiology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Rapid/Point-of-Care Diagnostics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Other Technologies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 COVID-19 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Influenza market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Respiratory Syncytial Virus market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Tuberculosis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Non-tuberculosis Mycobacterium Testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Bacterial Pneumonia Testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Other Respiratory Disease Testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Diagnostic Laboratories market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Other End Users market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 North America infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U S infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Canada infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Europe infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 UK infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Germany infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 France infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Spain infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Italy infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Norway infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Sweden infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Pacific infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 China infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Japan infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 India infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 South Korea infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Australia infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Argentina infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Middle East and Africa infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 South Africa infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Saudi Arabia infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 UAE infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Kuwait infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 List of key emerging company's/Allergen disruptors/innovators